Sarah Y. Neshat

1.0k total citations
11 papers, 229 citations indexed

About

Sarah Y. Neshat is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sarah Y. Neshat has authored 11 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Sarah Y. Neshat's work include Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). Sarah Y. Neshat is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). Sarah Y. Neshat collaborates with scholars based in United States, United Kingdom and Ukraine. Sarah Y. Neshat's co-authors include Jordan J. Green, Joshua C. Doloff, Stephany Y. Tzeng, Yuanjia Wang, Anthony Tuesca, Randall A. Meyer, José Luís Santos, Amanda Rakoski, Savannah Est‐Witte and Johan Karlsson and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and International Journal of Molecular Sciences.

In The Last Decade

Sarah Y. Neshat

10 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Y. Neshat United States	7	116	60	41	30	30	11	229
Zhenghu Jia China	11	101 0.9×	128 2.1×	46 1.1×	26 0.9×	14 0.5×	15	257
Shuangshuang Zhao China	10	118 1.0×	40 0.7×	27 0.7×	57 1.9×	15 0.5×	33	306
Morteza Akbari Iran	10	98 0.8×	75 1.3×	64 1.6×	22 0.7×	14 0.5×	23	302
Ziqi Lin China	9	129 1.1×	28 0.5×	49 1.2×	37 1.2×	12 0.4×	18	273
Jie Peng China	11	203 1.8×	42 0.7×	37 0.9×	33 1.1×	83 2.8×	22	315
Samaneh Khorrami Iran	11	166 1.4×	68 1.1×	62 1.5×	22 0.7×	12 0.4×	21	325
Ting Xie China	8	192 1.7×	31 0.5×	37 0.9×	101 3.4×	8 0.3×	19	366
Xiu Teng China	9	74 0.6×	97 1.6×	32 0.8×	27 0.9×	14 0.5×	15	199
Jiaqi Yang China	8	232 2.0×	29 0.5×	75 1.8×	37 1.2×	41 1.4×	23	373

Countries citing papers authored by Sarah Y. Neshat

Since Specialization

Citations

This map shows the geographic impact of Sarah Y. Neshat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Y. Neshat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Y. Neshat more than expected).

Fields of papers citing papers by Sarah Y. Neshat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Y. Neshat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Y. Neshat. The network helps show where Sarah Y. Neshat may publish in the future.

Co-authorship network of co-authors of Sarah Y. Neshat

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Y. Neshat. A scholar is included among the top collaborators of Sarah Y. Neshat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Y. Neshat. Sarah Y. Neshat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Neshat, Sarah Y., et al.. (2026). Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion. Science Advances. 12(11). eadz1722–eadz1722.

Est‐Witte, Savannah, Shuyi Li, Sarah Y. Neshat, et al.. (2024). Alginate-based artificial antigen presenting cells expand functional CD8+ T cells with memory characteristics for adoptive cell therapy. Biomaterials. 313. 122773–122773. 6 indexed citations

Neshat, Sarah Y., Savannah Est‐Witte, Johan Karlsson, et al.. (2023). Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors. Biomaterials. 300. 122185–122185. 30 indexed citations

Neshat, Sarah Y., Stuart J. Bauer, Kelly R. Rhodes, et al.. (2023). Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles. ACS Biomaterials Science & Engineering. 9(6). 3522–3534. 6 indexed citations

Wilson, David R., Stephany Y. Tzeng, Yuan Rui, et al.. (2023). Biodegradable Polyester Nanoparticle Vaccines Deliver Self‐Amplifying mRNA in Mice at Low Doses. Advanced Therapeutics. 6(5). 8 indexed citations

Rhodes, Kelly R., Stephany Y. Tzeng, Marcos Iglesias, et al.. (2023). Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis. Science Advances. 9(22). eadd8693–eadd8693. 19 indexed citations

Meyer, Randall A., Sarah Y. Neshat, Jordan J. Green, José Luís Santos, & Anthony Tuesca. (2022). Targeting strategies for mRNA delivery. Materials Today Advances. 14. 100240–100240. 42 indexed citations

Neshat, Sarah Y., et al.. (2021). Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. International Journal of Molecular Sciences. 22(13). 6777–6777. 64 indexed citations

Neshat, Sarah Y., et al.. (2021). Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity. Advanced Drug Delivery Reviews. 179. 113920–113920. 21 indexed citations

10.

Neshat, Sarah Y., et al.. (2021). Crystallization of the Multi-Receptor Tyrosine Kinase Inhibitor Sorafenib for Controlled Long-Term Drug Delivery Following a Single Injection. Cellular and Molecular Bioengineering. 14(5). 471–486. 1 indexed citations

11.

Neshat, Sarah Y., Stephany Y. Tzeng, & Jordan J. Green. (2020). Gene delivery for immunoengineering. Current Opinion in Biotechnology. 66. 1–10. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact